ArticleJournal of clinical microbiology2012
Sulfonamide resistance in isolates of Nocardia spp. from a US multicenter survey.
Article in Journal of clinical microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
59 citing papers in PubMed, 1 synthesis or guideline pooled it, 131 citations in OpenAlex.
- Nocardiosis: A Neglected Disease.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2020Pooled it
- Rare bacterial infections and metagenomics: current diagnostic and therapeutic challenges-a literature review.Infection · 2026Review
- Risk factors for mortality after nocardiosis in Southern France (2014-2024).IJID regions · 2026Article
- PulmonaryCase reports in infectious diseases · 2026Article
- Case Report: pharmaceutical care in a case of complicated urinary tract infection combined with disseminatedFrontiers in medicine · 2026Article
- Review
- Successful Treatment of Brain Abscess Caused byMicroorganisms · 2025Article
- Necrotizing soft tissue infection due toIDCases · 2025Article
- Clinical profile and outcomes of pulmonary nocardiosis in India: a systematic review of individual cases.Le infezioni in medicina · 2025Review
- Multiple skin abscesses due to Nocardia neocaledoniensis: a case report and literature review.BMC infectious diseases · 2024Review
- Brain abscess caused by Nocardia farcinica in a person living with HIV.BMC infectious diseases · 2024Article
- A Case of Yellow Nail Syndrome Complicated with Pulmonary Infection Due toInfectious disease reports · 2024Article
- Comparison of Clinical Characteristics and Treatment Outcome Between Localized and Disseminated Nocardiosis in a Tertiary Hospital in China.Infection and drug resistance · 2024Article
- Article
- Invasive Nocardia Infections across Distinct Geographic Regions, United States.Emerging infectious diseases · 2023Review
- Cerebral Abscess Due to Nocardia beijingensis Associated With HIV: Case Report and Mini Review.Cureus · 2023Article
- Nocardia caishijiensis infection: a case report and review of the literature.BMC infectious diseases · 2023Review
- Updated Review onClinical microbiology reviews · 2022Review
- A fatal case of disseminated nocardiosis due to Nocardia otitidiscaviarum resistant to trimethoprim-sulfamethoxazole: case report and literature review.Annals of clinical microbiology and antimicrobials · 2022Review
- MLSA phylogeny and antimicrobial susceptibility of clinical Nocardia isolates: a multicenter retrospective study in China.BMC microbiology · 2021Article
Corrections and comments
- Commented on by
Authors and funding
12 authors at 6 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent reports of increasing in vitro sulfonamide resistance in Nocardia prompted us to investigate the findings. Despite the reports, there is a paucity of clinical reports of sulfonamide failure in treatment of nocardia disease. We reviewed 552 recent susceptibilities of clinical isolates of Nocardia from six major laboratories in the United States, and only 2% of the isolates were found to have resistant MICs of trimethoprim-sulfamethoxazole and/or sulfamethoxazole. We hypothesize that the discrepancies in the apparent sulfonamide resistance between our study and the previous findings may be associated with difficulty in the laboratory interpretation of in vitro MICs for trimethoprim-sulfamethoxazole and sulfamethoxazole and the lack of quality controls for Nocardia for these agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.